There is one non randomized prospective cohort study suggesting that HCC was detected earlier and was more often resectable in patients who had twice yearly screening with serum AFP and hepatic US than in patients who had usual care [105]. The gene discussed is AFP; the disease is hepatocellular carcinoma.